4-[2-(CHLOROMETHYL)PHENYL]MORPHOLINE, 95.0%, 250mg

Fmoc-Ser(Bzl)-OH, 95%, 10g

Calcium sulphate, min. 98%, pure, anhydrous, 500 g, plastic packaging.

Ethyl 4-chloro-6-fluoroquinoline-3-carboxylate, 95.0%, 1g

Spiro[2.4]heptan-5-ol, 98%, 1g

(2E)-1-(3-chlorophenyl)-3-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 10g

(1R*,4R*)-N1-(3-Nitrobenzyl)cyclohexane-1,4-diamine dihydrochloride, 1g

Benzyl (4,4-difluoropiperidin-3-yl)carbamate hydrochloride, 95.0%, 250mg

1-(2-CHLOROPYRIDIN-4-YL)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 1g

4,5,6,7-Tetrahydro-1H-4,7-methanoindole-2-carboxylic acid, 97%, 1g

2-[(4R)-4,5-DIHYDRO-4-ISOPROPYL-2-OXAZOLYL]PYRIDINE, 98%, 25g

Methyl 5-bromo-4-methyl-1H-indole-2-carboxylate, 95%, 250mg

iScope IS.1153-EPL/DF Triocular with E-plan objectives and Rackless cross table (dark field contrast application)